NASDAQ:DNAY
Delisted
Codex DNA, Inc. Stock News
$1.89
+0 (+0%)
At Close: Apr 19, 2023
Telesis Bio, Inc. (DNAY) Q3 2022 Earnings Call Transcript
08:53pm, Saturday, 12'th Nov 2022
Telesis Bio, Inc. (NASDAQ:DNAY ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Todd Nelson - CEO Brent Hunter - VP, Finance Conference Call Participants Brandon Cou
Codex DNA (DNAY) Reports Q3 Loss, Tops Revenue Estimates
09:04pm, Tuesday, 08'th Nov 2022
Codex DNA (DNAY) delivered earnings and revenue surprises of 12.50% and 25.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Telesis Bio to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 8
04:19pm, Wednesday, 02'nd Nov 2022
SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2022 f
Codex DNA (DNAY) Could Find Support Soon, Here's Why You Should Buy the Stock Now
11:18am, Friday, 26'th Aug 2022
After losing some value lately, a hammer chart pattern has been formed for Codex DNA (DNAY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revis
Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q2 2022 Results - Earnings Call Transcript
08:26am, Sunday, 14'th Aug 2022
Codex DNA, Inc. (NASDAQ:DNAY ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Todd Nelson - Chief Executive Officer Brent Hunter - VP of Finance Conference Call Partic
Codex DNA (DNAY) Reports Q2 Loss, Tops Revenue Estimates
09:04pm, Tuesday, 09'th Aug 2022
Codex DNA (DNAY) delivered earnings and revenue surprises of 1.96% and 22.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Codex DNA to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022
04:05pm, Tuesday, 02'nd Aug 2022
SAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its second quarter 2022 fin
Codex DNA to Present at the 2022 Jefferies Healthcare Conference
08:03am, Thursday, 02'nd Jun 2022
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company's chief ex
Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q1 2022 Results - Earnings Call Transcript
11:28pm, Saturday, 14'th May 2022
Codex DNA, Inc. (NASDAQ:DNAY ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Richard Lepke - Director, Investor Relations Todd Nelson - Chief Executive Officer Jennifer
Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022
08:03am, Tuesday, 03'rd May 2022
SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its first quarter 2022 finan
Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q4 2021 Results - Earnings Call Transcript
10:31pm, Tuesday, 22'nd Mar 2022
Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q4 2021 Results - Earnings Call Transcript
Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022
08:03am, Thursday, 03'rd Mar 2022
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced details for its first Investor R&D Webinar. Man
Codex DNA to Report Fourth Quarter 2021 Financial Results on Tuesday, March 22, 2022
08:03am, Wednesday, 02'nd Mar 2022
SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its fourth quarter 2021 fi
Codex DNA to Present at the Cowen 42nd Annual Healthcare Conference
08:03am, Thursday, 24'th Feb 2022
SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company's chief ex
